Tag: Cancer: Rectal

Long-term aspirin use before diagnosis also linked to lower odds of diagnosis with distant metastases

Inverse association seen for aspirin users starting use before age 70, but not for those initiating use at or after age 70 years

Colorectal cancer test receipt near target in 2018, with 66.9 percent of adults aged 50 to 75 years up to date with testing

Authors say more nuanced approach needed to understand link between body weight and risk for colorectal cancer

Irinotecan, cetuximab, and vemurafenib improve progression-free survival in BRAF^V600E-mutated colorectal cancer

Adenocarcinomas increasing in most early-onset subgroups; carcinoid tumors increasing more steeply in all age groups

Authors say these findings suggest no need for intensive surveillance after three years

High level of organ preservation, improved QoL seen with short-course radiotherapy followed by transanal endoscopic microsurgery

Nearly one in 16 U.S. counties are hot spots, with the majority in the South

Pembrolizumab superior to chemo for progression-free survival among patients who had not previously received treatment